Crowell represented Marshall Wace on the deal. Marshall Wace, a global alternative investment manager, announced a $41.5 million Series B round of funding of Parse Biosciences. Marshall...
Parse Biosciences’ $41.5 Million Series B Financing
Century Therapeutics’ $160-million Series C Financing
Brown Rudnick LLP advised lead investor Casdin Capital and a syndicate of new investors, while White & Case LLP advised Qatar Investment Authority on the deal....